80 FR 36539 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 122 (June 25, 2015)

The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the collection of Minimum Data Elements (MDE) for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). CDC collects information about the cancer screening services provided through the NBCCEDP to support program management.

[Federal Register Volume 80, Number 122 (Thursday, June 25, 2015)]
[Notices]
[Pages 36539-36540]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-15550]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-15-0571]; [Docket No. CDC-2015-0015]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the collection of 
Minimum Data Elements (MDE) for the National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP). CDC collects information about the 
cancer screening services provided through the NBCCEDP to support 
program management.

DATES: Written comments must be received on or before August 24, 2015.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0015 by any of the following methods:
    Federal eRulemaking Portal: Regulation.gov. Follow the instructions 
for submitting comments.
    Mail: Leroy A. Richardson, Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note:  All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of 
Management and Budget (OMB) for each collection of information they 
conduct or sponsor. In addition, the PRA also requires Federal agencies 
to provide a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each new proposed 
collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Minimum Data Elements (MDE) for the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) (OMB No. 0920-0571, exp. 10/
31/2015)--Extension--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    Many cancer-related deaths in women could be avoided by increased 
utilization of appropriate screening and early detection tests for 
breast and cervical cancer. Mammography is extremely valuable as an 
early detection tool because it can detect breast cancer well before 
the woman can feel the lump, when the cancer is still in an early and 
more treatable stage. Similarly, a substantial proportion of cervical 
cancer-related deaths could be prevented through the detection and 
treatment of precancerous lesions. The Papanicolaou (Pap) test is the 
primary method of detecting both precancerous cervical lesions as well 
as invasive cervical cancer. Mammography and Pap tests are underused by 
women who have no source or no regular source of health care and women 
without health insurance.
    Despite the availability and increased use of effective screening 
and early detection tests for breast and cervical cancers, the American 
Cancer Society (ACS) estimates that 231,840 new cases of invasive 
breast cancer will be diagnosed among women in 2015, and 40,290 women 
will die of this disease. The ACS also estimates that 12,900 new cases 
of invasive cervical cancer will be diagnosed in 2015, and 4,100 women 
will die of this disease.
    The CDC's National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP) provides screening services to underserved women 
through cooperative agreements with 50 States, the District of 
Columbia, 5 U.S. Territories, and 11 American Indian/Alaska Native 
tribal programs. The program was established in response to the Breast 
and Cervical Cancer Mortality Prevention Act of 1990. Screening 
services include clinical breast examinations, mammograms and Pap 
tests, as well as timely and adequate diagnostic testing for abnormal 
results,

[[Page 36540]]

and referrals to treatment for cancers detected. NBCCEDP awardees 
collect patient-level screening and tracking data to manage the program 
and clinical services. A de-identified subset of data on patient 
demographics, screening tests and outcomes are reported by each awardee 
to CDC twice per year.
    CDC plans to request OMB approval to collect MDE information for an 
additional three years. There are no changes to the currently approved 
minimum data elements, electronic data collection procedures, or the 
estimated burden. Because NBCCEDP awardees already collect and 
aggregate data at the state, territory and tribal level, the additional 
burden of submitting data to CDC will be modest. CDC will use the 
information to monitor and evaluate NBCCEDP awardees; improve the 
availability and quality of screening and diagnostic services for 
underserved women; develop outreach strategies for women who are never 
or rarely screened for breast and cervical cancer; report program 
results to stakeholders including Congress and other legislative 
authorities; and inform program planning and management.
    There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                   Number of     Average  burden
     Type of respondents         Form name        Number of      responses per    per  response    Total burden
                                                 respondents       respondent       (in hrs.)        (in hrs.)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees............  Minimum Data                 67                2                4              536
                               Elements.
                                              ------------------------------------------------------------------
    Total...................  ...............  ...............  ...............  ...............             536
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-15550 Filed 6-24-15; 8:45 am]
 BILLING CODE 4163-18-P